Durable treatment-free remission in patients with chronic myeloid leukemia in chronic phase following frontline nilotinib: 96-week update of the ENESTfreedom study

  1. Ross, D.M.
  2. Masszi, T.
  3. Gómez Casares, M.T.
  4. Hellmann, A.
  5. Stentoft, J.
  6. Conneally, E.
  7. Garcia-Gutierrez, V.
  8. Gattermann, N.
  9. le Coutre, P.D.
  10. Martino, B.
  11. Saussele, S.
  12. Giles, F.J.
  13. Radich, J.P.
  14. Saglio, G.
  15. Deng, W.
  16. Krunic, N.
  17. Bédoucha, V.
  18. Gopalakrishna, P.
  19. Hochhaus, A.
Revue:
Journal of Cancer Research and Clinical Oncology

ISSN: 1432-1335,  0171-5216

Année de publication: 2018

Volumen: 144

Número: 5

Pages: 945-954

Type: Article

DOI: 10.1007/S00432-018-2604-X GOOGLE SCHOLAR lock_openAccès ouvert editor

Objectifs de Développement Durable

La source de données: Scopus